Mapping Pathways is a multi-national project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral-based prevention strategies to end the HIV/AIDS epidemic. The evidence base is more than results from clinical trials - it must include stakeholder and community perspectives as well.

05 July 2011

Millions will die if India stops AIDS drugs

Via Reuters, by Nita Bhalla.

The EU and India are currently negotiating a free-trade agreement, which campaigners say will restrict India's ability to produce anti-retroviral (ARV) drugs, preventing the world's poor from accessing cheap drugs for their treatment.

"India should resist removing any flexibility because any trade agreement which could lead to India not being able to produce will be terrible for the rest of the world," said Michel Sidibe, executive director for the Joint United Nations Programme on HIV/AIDS (UNAIDS).

"Millions of people will die if India cannot produce and Africa will be the most affected. For me, it is an issue of life or death," he told Reuters in an interview, adding that about 86 percent of people on treatment were taking drugs made in India.

The EU-India trade deal includes measures that could delay or restrict competition from generic medicines by extending patent terms, requiring data exclusivity and tightening border enforcement rules.

Such moves could drive up prices for India's anti-retroviral treatments, limit dosage options and delay access to newer and better drugs, said a U.N. report in September last year.


REVERSING GAINS MADE

Thirty years after the HIV/AIDS virus was first discovered, experts say while substantial progress has been made by the global community in stemming it, only a fraction of those living with the illness are on medication.

At a high level U.N. meeting last month, nations agreed on a set of ambitious targets to rid the world of disease, including scaling up the provision of generics to reach 15 million patients from six million by 2015.
The trade deal, Sidibe said, would reverse many of the gains made in improving the lives of the world's poor.

Read the rest here.

[Content that is linked from other sources is for informational purposes and should not construe a Mapping Pathways position.]

No comments:

Post a Comment